Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT00271479
Previous Study | Return to List | Next Study

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

This study has been completed.
Norwegian Institute of Public Health
University of Oslo
Medecins Sans Frontieres, Netherlands
Information provided by:
Epicentre Identifier:
First received: December 29, 2005
Last updated: December 21, 2006
Last verified: December 2006